VANCOUVER, British Columbia — Roche-Genentech is working toward a future in which physician and machine come together to improve outcomes for patients.
Executives and researchers shared their vision here at a company-sponsored event during the Association for Research in Vision and Ophthalmology meeting for the potential of using technology for not only personalized treatment but disease prevention.
“It’s very different than what we’ve done, which is enroll patients with fairly advanced disease in clinical trials,” Jill Hopkins, MD, FRSC, project team lead,
Uncategorized